Apyx Medical (APYX) Retained Earnings (2010 - 2026)

Apyx Medical has reported Retained Earnings for 17 years, with the latest figure at -$91.2 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 11.17% year-over-year to -$91.2 million; the trailing twelve-month figure through Mar 2026 stood at -$91.2 million (down 11.17% YoY), and the FY2025 full-year result was -$89.1 million, down 14.39% from the prior year.
• Retained Earnings for Q1 2026 stood at -$91.2 million, down from -$89.1 million in the prior quarter.
• The five-year high for Retained Earnings was -$18.5 million in Q1 2022, with the low at -$91.2 million in Q1 2026.
• Historically, Retained Earnings has averaged -$59.1 million across 5 years, with a median of -$62.0 million in 2024.
• Annual changes were most pronounced in 2022 — Retained Earnings plunged 711.23% — and 2026, when it retreated 11.17%.
• Apyx Medical's Retained Earnings stood at -$35.7 million in 2022, then sank by 52.37% to -$54.4 million in 2023, then plunged by 43.09% to -$77.9 million in 2024, then fell by 14.39% to -$89.1 million in 2025, then declined by 2.37% to -$91.2 million in 2026.
• The last three Retained Earnings figures came in at -$91.2 million (Q1 2026), -$89.1 million (Q4 2025), and -$87.8 million (Q3 2025), per Business Quant data.